Rick Simpson's Cancer Cures Cannabis Oil Movement

Rick Simpson's "Canadian Cancer Cures" and the Rising Cannabis Oil Movement
By Paul Fassa

Guest Writer for Wake Up World

Cannabis oil and its variations have made mainstream news with its positive effects on various diseases, including cancer, a disease that conventional medical therapies often complicate or worsen. All with great expense.

Earlier this century, Rick Simpson had discovered a way to heal his own cancer, and then had shared his remedy at no cost with others in the small town of Maccan, Nova Scotia. According to the Maccan community, Rick offered impressive results without side effects at no cost, and the local residents took advantage. The reported results were amazing with not only cancer patients, but others with "incurable" disorders.

The medical industry is geared toward patented pharmaceuticals, so there are often obstacles promoting 'alternative' (non-pharmaceutical) remedies. But now here was an additional obstacle. The treatment that was working so well was hemp oil with the illegal substance THC. The small Canadian community's success with reversing cancer naturally was forcibly stopped, driving its provider into exile in Europe.

This was the beginning of the recent surge of cannabis oil being sought after by people with cancer, Crohn's Disease, children's chronic epileptic seizures, and other ailments. According to research, this oil is more potent medically than smoking, juicing or even vaporizing cannabis. It's not just for "getting high".

Rick's Reasons

Rick Simpson experienced a head injury at work in 1997. Afterward he was afflicted with a severe post concussion syndrome. He was put on pharmaceuticals, which created dysfunctional side effects. He heard about the medical benefits of marijuana. So Rick purchased a bag and began smoking daily.

Eventually, both the post concussion syndrome and the pharmaceutical drug fog vanished completely. Rick's doctor discouraged him from smoking. So Rick decided on growing his own THC hemp and extracting the oil from whole plants. He reduced a pound of plants by slow boiling in a solution to get a small tube of thick THC concentrated oil.

Soon after he began, Rick was diagnosed with basal cell carcinoma. After one of the three cancers was removed surgically, it came back. So he decided to try the THC laden hemp oil topically. According to Rick, within days, all three skin cancers were completely healed and he deduced that THC hemp oil killed cancer, but smoking marijuana would not.

Helping Others

So Rick began sharing the hemp oil within his community without charging. Reports from the Maccan community are that remarkable improvements were seen by taking a small dose orally, twice daily, or applying it topically. Rick Dwyer, the manager of the local Royal American Legionbranch was very impressed. His father's terminal lung cancer was reportedly reversed in weeks from Rick's oil after the hospital had sent him home to die.

Quickly the word was out locally about Simpson's THC hemp oil. Several others are reported to have recovered or greatly benefited without side effects from a variety of serious ailments, including cancer, heart disease, and MS.

Then both Ricks, Simpson and Dwyer, decided there should be town meetings in the Legion hall about the THC hemp oil, and that they would see what to do about spreading the word.

The Consequence of Healing

The publicity from a curious Canadian media raised enough of a stir for the Legion to close the Maccan branch and fire Rick Dwyer as the local manager. Then the locals reportedly became concerned when the Royal Canadian Mounted Police (RMPC) clamped down on Rick Simpson's life saving operation. Rick Simpson decided to pre-empt that strong possibility. He went to Halifax, Nova Scotia, to acquire legal exemption for using his oil as medical marijuana. He took 14 dozen sworn affidavits from those he had helped in Maccan. But those affidavits were disregarded and his request was turned down.

Nine months later he appealed to the Nova Scotia Supreme Court. This time, Rick had ten now-healthy citizens and six doctors present to testify. Their testimonies were not even allowed. His appeal was rejected, and his little local operation of supplying free cannabis oil was threatened. According to Rick, the benefits of natural cannabis were being suppressed, and that the cancer industry is focused on treating, not curing.

Fortunately, minor variations of Rick Simpson's oil are being produced and used successfully in legal 'medical marijuana' states. And there are a few individuals who produce the oil that can send it to others safely. But it seems as though the cancer industry on the whole doesn't want to know about a product that can't be patented.

A well produced documentary of Rick's saga with instructions on how to make the oil was produced with the help of friends — cleverly titled "Run From the Cure". He used naptha as a solvent. But many others reportedly use 195 proof pure grain alcohol, which is considered by most to be safer. You can view the first documentary "Run From the Cure" below.

Of course, we encourage you to do your own research, consult with your preferred health care professional(s), and make informed decisions.

Source: Wake Up World

About the author:

Paul Fassa is a truth seeking writer whose articles appear on several alternative health sites. His blog is HealthMaven, Escape from the Medical Mafia Matrix.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment.


*****​


Pot for Parkinsons

By Sayer Ji

Contributing Writer for Wake Up World

Could the very plant that for decades was accused of "frying" users' brains be far superior to pharmaceuticals in treating the "incurable" neurodegenerative condition known as Parkinson's disease?

Despite the political controversy surrounding medical marijuana use in the country, research has begun to emerge showing that a component of this plant known as cannabidiol (CBD), and which does not have the controversial psychoactive properties associated with tetrahydrocannabinol (THC), may have a wide range of therapeutic applications, including treating conditions that are refractory to conventional drug-based approaches.

One such condition is Parkinson's disease, to which there is, at present, no effective conventional treatment. In fact, the primary treatment involves dopamine increasing drugs that also increase a neurotoxic metabolite known as with 6-hydroxy-dopamine, and which therefore can actually accelerate the progression of the disease. This is why natural alternatives that are safe, effective, and backed up by scientific evidence, are so needed today. Thankfully, preclinical research on cannabidiol has already revealed some promising results, including two studies in animal models of Parkinson's disease (PD) assessing its neuroprotective properties:

"In the first one, Lastres-Becker et al. (2005) showed that the administration of CBD counteracted neurodegeneration caused by the injection of 6-hydroxy-dopamine in the medial prosencephalic bundle, an effect that could be related to the modulation of glial cells and to antioxidant effects (Lastres- Becker et al., 2005). In the next year, Garcia-Arencibia et al. (2007) tested many cannabinoid compounds following the lesion of dopaminergic neurons in the substantia nigra with 6-hydroxy-dopamine and found that the acute administration of CBD seemed to have a neuroprotective action; nonetheless, the administration of CBD one week after the lesion had no significant effects (Garcia-Arencibia et al., 2007). This study also pointed to a possible antioxidant effect with the upregulation of mRNA of the enzyme Cu-Zn-superoxide dismutase following the administration of CBD." [1]

In addition to these animal studies, the following three human clinical trials have been conducted to evaluate cannabidiol's neuroprotective effects.

A 2006 study published in Biological Psychology titled, "Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users," investigated the N-acetylaspartate to creatine ratios (NAA/Cr) in the brain of regular cannabis users through magnetic resonance spectroscopy (H1-MRS) to assess the neurotoxic and neuroprotective effects of cannabinoids present in the drug and found a strong positive correlation between CBD and NAA/Cr in the globus pallidus and putamen.[2] According to the study, "the globus pallidum is the region with the highest amount of CB1-receptors in the brain and the target of neurostimulation in patients with Parkinson's disease, who developed a strong tremor. Our MRSI results support a positive effect of CBD on the putamen/globus pallidum region in cannabis use. Therefore, it may be promising to test a possible influence of the nonpsychotropic CBD in the onset of Parkinson's disease."
A 2009 study published in the Journal of Psychopharmacology titled, "Cannabidiol for the treatment of psychosis in Parkinson's disease,"[3] assessed the therapeutic use and neuroprotective effect of CBD in PD patients. The open label study was conducted with six patients with PD-related psychosis. They were administered CBD at doses ranging from 150 mg in the first week to 400 mg in the fourth and last week of treatment (doses were adjusted to optimize the clinical response). The study reported significant improvements in psychosis as well as in the total scores of a scale that measures general symptoms of PD (Unified Parkinson's disease rating scale — UPDRS)
A 2014 study published in the Journal of Psychopharmacology titled, "Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial," evaluated the effects of cannabidiol in Parkinson's disease patients, dividing 21 patients into 3 groups of 7 receiving either placebo, cannabidiol (CBD) 75 mg/day or CBD 300 mg/day. Increases in well-being and quality of life were observed in the 300 mg/day groups versus the placebo groups. The researchers hypothesized that these improvements may have been due to cannabidiol's "anxiolytic," "antidepressant," "anti-psychotic," and "sedative" properties.
These results, taken together with the results from the animal models of PD, indicate that CBD may provide a drug alternative in PD patients. Additionally, a new study published in Toxicology In Vitro titled,"The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease," makes the case for using cannabidiol in PD even more compelling by helping to illuminate some of the molecular mechanisms beneath its benefits.The study found that cannabidiol protects against the neurotoxin known as MPP(+), which is widely believed to be responsible for the damage to the dopamine-producing cells in the substania nigra of Parkison's patients, by preventing neuronal cell death and inducing neuritogenesis (a neuro-regenerative process for repairing damaged neurons). This mechanism was found to be independent of the neural growth factor (NGF) pathway, even though it involves NGF receptors. Cannabidiol was also found to increase the expression of axonal and synaptic proteins. The study concluded that CBD's neuroprotective properties might be of benefit to Parkinson's disease patients.

For additional research on how cannabis can contribute to mitigating neurodegenerative diseases read our article, "Marijuana Compound Found Superior To Drugs For Alzheimer's," and peruse the cannabis research database on GreenMedInfo.com. Also, for an extensive set of data on natural interventions for Parkinson's disease, view our database on the topic: Parkinson's disease research. Finally, peruse an extensive list of foods, spices, and natural substances that have neuritogenic properties here.

Article sources:

[1] Chagas MH, et al. J Psychopharmacol. 2014 Nov;28(11):1088-98. doi: 10.1177/0269881114550355. Epub 2014 Sep 18. Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial.
[2] Hermann D, Sartorius A, Welzel H, et al. (2007) Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychiatry 61: 1281—1289.
[3] Zuardi AW, Crippa JA, Hallak JE, et al. (2009) Cannabidiol for the treatment of psychosis in Parkinson's disease. J Psychopharmacol 23:979—983.

About the author:

Sayer-Ji

Sayer Ji is on the Board of Governors for the National Health Federation and Fearless Parent, Steering Committee Member of the Global GMO Free Coalition (GGFC), a reviewer at the International Journal of Human Nutrition and Functional Medicine, and founder of GreenMedInfo.com — an open access, evidence-based resource supporting natural and integrative modalities.

In 1995 Sayer received a BA degree in Philosophy from Rutgers University, where he studied under the American philosopher Dr. Bruce W. Wilshire, with a focus on the philosophy of science. In 1996, following residency at the Zen Mountain Monastery in upstate New York, he embarked on a 5 year journey of service as a counsellor-teacher and wilderness therapy specialist for various organizations that serve underprivileged and/or adjudicated populations. Since 2003, Sayer has served as a patient advocate and an educator and consultant for the natural health and wellness field.

Source: Wake Up World
 
My Mum has Parkinsons. Thanks. I shall read through..
 
Back
Top Bottom